Lifetime depression and anxiety increase prevalent psychological symptoms and worsen glycemic control in type 2 diabetes: The Fremantle Diabetes Study Phase II

Diabetes Research and Clinical Practice

Volumn 122, Issue , 2016, Pages 190-197

  Whitworth, S R ^a   Bruce, D G ^b   Starkstein, S E ^a   Davis, W A ^b   Davis, T M E ^b   Bucks, R S ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Anxiety; Behaviour; Depression; Diabetes

Indexed keywords

HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL;

AGE; AGED; ANXIETY ASSESSMENT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; BRIEF LIFE TIME DEPRESSION SCALE; COHORT ANALYSIS; DEPRESSION ASSESSMENT; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENERALIZED ANXIETY DISORDER; GENERALIZED ANXIETY DISORDER SCALE LIFETIME; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MARRIAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT HEALTH QUESTIONNAIRE 9; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SELF MONITORING; SEX DIFFERENCE; SMOKING; ANXIETY DISORDERS; BLOOD; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; WESTERN AUSTRALIA;

ANXIETY DISORDERS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; WESTERN AUSTRALIA;

EID: 84995555599     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2016.10.023     Document Type: Article

References (27)

1. [1] de Groot, M., Anderson, R., Freedland, K.E., Clouse, R.E., Lustman, P.J., Assocation of depression and diabetes complications: a meta-analysis. Psychosom Med 63 (2001), 619–630.
2. [2] Katon, W., Von Korff, M., Ciechanowski, P., Russo, J., Lin, E., Simon, G., et al. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 27 (2004), 914–920.
3. [3] Gonzalez, J.S., Peyrot, M., McCarl, L.A., Collins, E.M., Serpa, L., Mimiaga, M.J., et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 31 (2008), 2398–2403, 10.2337/dc08-1341.
4. [4] Trento, M., Charrier, L., Salassa, M., Merlo, S., Passera, P., Cavallo, F., et al. Depression, anxiety and cognitive function in patients with type 2 diabetes: an 8-year prospective observational study. Acta Diabetol 52 (2015), 1157–1166.
5. [5] Trento, M., Trevisan, M., Raballo, M., Passera, P., Charrier, L., Cavallo, F., et al. Depression, anxiety, cognitive impairment and their association with clinical and demographic variables in people with type 2 diabetes: a 4-year prospective study. J Endocrinol Invest 37 (2014), 79–85, 10.1007/s40618-013-0028-7.
6. [6] Renn, B.N., Feliciano, L., Segal, D.L., The bidirectional relationship of depression and diabetes: a systematic review. Clin Psychol Rev 31 (2011), 1239–1246, 10.1016/j.cpr.2011.08.001.
7. [7] Bruce, D.G., Davis, W.A., Cetrullo, V., Starkstein, S.E., Davis, T.M.E., Clinical impact of the temporal relationship between depression and type 2 diabetes: the Fremantle Diabetes Study Phase II. PLoS One 8 (2013), 1–7.
8. [8] Wagner, J.A., Tennen, H., Osborn, C.Y., Lifetime depression and diabetes self-management in women with type 2 diabetes: a case-control study. Diabet Med 27 (2010), 713–717, 10.1111/j.1464-5491.2010.02996.x.
9. [9] Marcus, M.D., Wing, R.R., Guare, J., Blair, E.H., Jawad, A., Lifetime prevalence of major depression and its effect on treatment outcome in obese type II diabetic patients. Diabetes Care 15 (1992), 253–255.
10. [10] Grigsby, A.B., Anderson, R.J., Freedland, K.E., Clouse, R.E., Lustman, P.J., Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res 53 (2002), 1053–1060, 10.1016/S0022-3999(02)00417-8.
11. [11] Collins, M.M., Corcoran, P., Perry, I.J., Anxiety and depression symptoms in patients with diabetes. Diabet Med 26 (2009), 153–161, 10.1111/j.1464-5491.2008.02648.x.
12. [12] Fisher, L., Skaff, M.M., Mullan, J.T., Arean, P., Glasgow, R., Masharani, U., A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabet Med 25 (2008), 1096–1101.
13. [13] Schoevers, R.A., Deeg, D.J.H., van Tilburg, W., Beekman, A.T.F., Depression and generalized anxiety disorder: co-occurrence and longitudinal patterns in elderly patients. Am J Geriatr Psychiatry 13 (2005), 31–39.
14. [14] Starkstein, S.E., Davis, W.A., Dragovic, M., Cetrullo, V., Davis, T.M.E., Bruce, D.G., Diagnostic criteria for depression in type 2 diabetes: a data-driven approach. PLoS One, 9, 2014, e112049.
15. [15] Davis, T.M.E., Bruce, D.G., Davis, W.A., Cohort profile: the fremantle diabetes study. Int J Epidemiol 42 (2013), 412–421, 10.1093/ije/dys065.
16. [16] Kroenke, K., Spitzer, R.L., The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann 32 (2002), 509–515.
17. [17] Spitzer, R.L., Kroenke, K., Williams, J.B., Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. J Am Med Assoc 282 (1999), 1737–1744.
18. [18] van Steenbergen-Weijenburg, K.M., de Vroege, L., Ploeger, R.R., Brals, J.W., Vloedbeld, M.G., Veneman, T.F., et al. Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC Health Serv Res, 10, 2010, 235.
19. [19] Bruce, D.G., Davis, W.A., Hunter, M.L., Peters, K.E., Davis, T.M., Starkstein, S.E., Lifetime depression history and depression risk in type 2 diabetes: a case-control study. J Diabetes Complications 30 (2016), 38–42.
20. [20] Hayes, A.F., Introduction to mediation, moderation, and conditional process analysis. 2013, Guilford Press, New York.
21. [21] Hayes, A.F., Preacher, K.J., Statistical mediation analysis with a multicategorical independent variable. Br J Math Stat Psychol 67 (2014), 451–470.
22. [22] Hayes, A.F., Scharkow, M., The relative trustworthiness of inferential tests of the indirect effect in statistical mediation analysis: does method really matter?. Psychol Sci 24 (2013), 1918–1927, 10.1177/0956797613480187.
23. [23] Rothman, K.J., No adjustments are needed for multiple comparisons. Epidemiology 1 (1990), 43–46.
24. [24] Katon, W.J., Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 54 (2003), 216–226, 10.1016/s0006-3223(03)00273-7.
25. [25] Lin, E.H.B., Katon, W., Michael Von, K., Rutter, C., et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 27 (2004), 2154–2160.
26. [26] Skinner, T.C., Carey, M.E., Cradock, S., Dallosso, H.M., Daly, H., Davies, M.J., et al. Depressive symptoms in the first year from diagnosis of type 2 diabetes: results from the DESMOND trial. Diabet Med, 2010, 965–967.
27. [27] Fisher, L., Mullan, J.T., Arean, P., Glasgow, R.E., Hessler, D., Masharani, U., Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care 33 (2010), 23–28, 10.2337/dc09-1238.